Gandin V - Search Results

1

RACK1 Function in Cell Motility and Protein Synthesis.

Gandin V, Senft D, Topisirovic I, Ronai ZA. Gandin V, et al. Genes Cancer. 2013 Sep;4(9-10):369-77. doi: 10.1177/1947601913486348. Genes Cancer. 2013. PMID: 24349634 Free PMC article. Review.

2

Co-translational mechanisms of quality control of newly synthesized polypeptides.

Gandin V, Topisirovic I. Gandin V, et al. Translation (Austin). 2014 Feb 13;2(1):e28109. doi: 10.4161/trla.28109. eCollection 2014. Translation (Austin). 2014. PMID: 26779401 Free PMC article. Review.

3

Cell biology. Trans-HSF1 express.

Gandin V, Topisirovic I. Gandin V, et al. Science. 2013 Jul 19;341(6143):242-3. doi: 10.1126/science.1242359. Science. 2013. PMID: 23869008 No abstract available.

4

Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex.

Gandin V, Gutierrez GJ, Brill LM, Varsano T, Feng Y, Aza-Blanc P, Au Q, McLaughlan S, Ferreira TA, Alain T, Sonenberg N, Topisirovic I, Ronai ZA. Gandin V, et al. Mol Cell Biol. 2013 Jul;33(13):2510-26. doi: 10.1128/MCB.01362-12. Epub 2013 Apr 22. Mol Cell Biol. 2013. PMID: 23608534 Free PMC article.

5

Distinct translational control in CD4+ T cell subsets.

Bjur E, Larsson O, Yurchenko E, Zheng L, Gandin V, Topisirovic I, Li S, Wagner CR, Sonenberg N, Piccirillo CA. Bjur E, et al. Among authors: gandin v. PLoS Genet. 2013 May;9(5):e1003494. doi: 10.1371/journal.pgen.1003494. Epub 2013 May 2. PLoS Genet. 2013. PMID: 23658533 Free PMC article.

6

Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase.

Zhu S, Rousseau P, Lauzon C, Gandin V, Topisirovic I, Autexier C. Zhu S, et al. Among authors: gandin v. Biochimie. 2014 Jun;101:93-103. doi: 10.1016/j.biochi.2013.12.023. Epub 2014 Jan 9. Biochimie. 2014. PMID: 24412622

7

Largen: a molecular regulator of mammalian cell size control.

Yamamoto K, Gandin V, Sasaki M, McCracken S, Li W, Silvester JL, Elia AJ, Wang F, Wakutani Y, Alexandrova R, Oo YD, Mullen PJ, Inoue S, Itsumi M, Lapin V, Haight J, Wakeham A, Shahinian A, Ikura M, Topisirovic I, Sonenberg N, Mak TW. Yamamoto K, et al. Among authors: gandin v. Mol Cell. 2014 Mar 20;53(6):904-15. doi: 10.1016/j.molcel.2014.02.028. Mol Cell. 2014. PMID: 24656129 Free article.

8

Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale.

Gandin V, Sikström K, Alain T, Morita M, McLaughlan S, Larsson O, Topisirovic I. Gandin V, et al. J Vis Exp. 2014 May 17;(87):51455. doi: 10.3791/51455. J Vis Exp. 2014. PMID: 24893926 Free PMC article.

9

eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.

Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, Gandin V, Liu Y, Topisirovic I, Sonenberg N. Alain T, et al. Among authors: gandin v. Cancer Res. 2012 Dec 15;72(24):6468-76. doi: 10.1158/0008-5472.CAN-12-2395. Epub 2012 Oct 24. Cancer Res. 2012. PMID: 23100465

10

The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.

Im YK, La Selva R, Gandin V, Ha JR, Sabourin V, Sonenberg N, Pawson T, Topisirovic I, Ursini-Siegel J. Im YK, et al. Among authors: gandin v. Oncogene. 2015 Mar 26;34(13):1729-35. doi: 10.1038/onc.2014.110. Epub 2014 May 19. Oncogene. 2015. PMID: 24837366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page